Logo

Qiagen Launches QIAseq SARS-CoV-2 Primer Panel for Tracking COVID-19 Mutations and Strains

Share this

Qiagen Launches QIAseq SARS-CoV-2 Primer Panel for Tracking COVID-19 Mutations and Strains

Shots:

  • Qiagen’s QIAseq SARS-CoV-2 primer panel provides optimized- single-day workflows to prepare libraries for sequencing as researchers use NGS to track changes in the viral genome
  • The two-step process uses advanced QIAseq technologies to conduct reverse transcription and cDNA synthesis from a viral RNA sample- then generate libraries compatible with Illumina sequencing platforms
  • The solution aims to accelerate research into COVID-19 prevention and treatment by enabling deeper and more holistic insights into the biology of SARS-CoV-2

­ Ref: Qiagen | Image: Euronews

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions